{"transactions":[{"id":4623721,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21616,"kind":"person","name":"Rogers Campbell","position":1,"cik":"0001585724","reported_name":"Rogers Campbell","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-09-21T22:19:36.000Z","date":"2026-09-18","kind":"exercise","planned":true,"acquired":false,"shares":850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on June 16, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests and becomes exercisable in monthly installments until July 1, 2027, subject to continued service through the applicable vesting date."}],"balance_after":70783,"derivative":{"exercise_price":2.22,"expiration_date":"2033-07-10","underlying":"Common Stock","underlying_shares":850},"source":{"system":"sec-edgar","filing":"0001464521-26-000152","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1585724/000146452126000152/form4.xml","form_type":"4"}},{"id":4623720,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21616,"kind":"person","name":"Rogers Campbell","position":1,"cik":"0001585724","reported_name":"Rogers Campbell","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-09-21T22:19:36.000Z","date":"2026-09-18","kind":"exercise","planned":true,"acquired":false,"shares":12329,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on June 16, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These stock options are fully exercisable."}],"balance_after":31456,"derivative":{"exercise_price":8.33,"expiration_date":"2030-02-28","underlying":"Common Stock","underlying_shares":12329},"source":{"system":"sec-edgar","filing":"0001464521-26-000152","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1585724/000146452126000152/form4.xml","form_type":"4"}},{"id":4623719,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21616,"kind":"person","name":"Rogers Campbell","position":1,"cik":"0001585724","reported_name":"Rogers Campbell","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-09-21T22:19:36.000Z","date":"2026-09-18","kind":"sale","planned":true,"acquired":false,"shares":19682,"price":50.15,"value":987052.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Includes the sale of 6,503 shares of common stock held and the option exercise and sale of 13,179 shares reported on this Form 4 that were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on June 16, 2026."}],"balance_after":79956,"source":{"system":"sec-edgar","filing":"0001464521-26-000152","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1585724/000146452126000152/form4.xml","form_type":"4"}},{"id":4623718,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21616,"kind":"person","name":"Rogers Campbell","position":1,"cik":"0001585724","reported_name":"Rogers Campbell","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-09-21T22:19:36.000Z","date":"2026-09-18","kind":"exercise","planned":true,"acquired":true,"shares":850,"price":2.22,"value":1887.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on June 16, 2026."}],"balance_after":99638,"source":{"system":"sec-edgar","filing":"0001464521-26-000152","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1585724/000146452126000152/form4.xml","form_type":"4"}},{"id":4623717,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21616,"kind":"person","name":"Rogers Campbell","position":1,"cik":"0001585724","reported_name":"Rogers Campbell","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-09-21T22:19:36.000Z","date":"2026-09-18","kind":"exercise","planned":true,"acquired":true,"shares":12329,"price":8.33,"value":102700.57,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on June 16, 2026."}],"balance_after":98788,"source":{"system":"sec-edgar","filing":"0001464521-26-000152","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1585724/000146452126000152/form4.xml","form_type":"4"}},{"id":681286,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21616,"kind":"person","name":"Rogers Campbell","position":1,"cik":"0001585724","reported_name":"Rogers Campbell","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options","published_at":"2026-08-20T01:04:56.000Z","date":"2026-08-17","kind":"exercise","planned":true,"acquired":false,"shares":9219,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in monthly installments until August 7, 2029, subject to continued service through the applicable vesting date."}],"balance_after":82972,"derivative":{"exercise_price":19,"expiration_date":"2035-08-07","underlying":"Common Stock","underlying_shares":9219},"source":{"system":"sec-edgar","filing":"0001464521-26-000135","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1464521/000146452126000135/form4.xml","form_type":"4"}},{"id":681285,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21616,"kind":"person","name":"Rogers Campbell","position":1,"cik":"0001585724","reported_name":"Rogers Campbell","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-08-20T01:04:56.000Z","date":"2026-08-17","kind":"sale","planned":true,"acquired":false,"shares":9219,"price":41.23,"value":380099.37,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 12, 2025."}],"balance_after":86459,"source":{"system":"sec-edgar","filing":"0001464521-26-000135","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1464521/000146452126000135/form4.xml","form_type":"4"}},{"id":681284,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21616,"kind":"person","name":"Rogers Campbell","position":1,"cik":"0001585724","reported_name":"Rogers Campbell","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-08-20T01:04:56.000Z","date":"2026-08-17","kind":"exercise","planned":true,"acquired":true,"shares":9219,"price":19,"value":175161.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 12, 2025."}],"balance_after":95678,"source":{"system":"sec-edgar","filing":"0001464521-26-000135","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1464521/000146452126000135/form4.xml","form_type":"4"}},{"id":691828,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21616,"kind":"person","name":"Rogers Campbell","position":1,"cik":"0001585724","reported_name":"Rogers Campbell","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-08-10T21:17:35.000Z","date":"2026-08-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":637,"price":28.82,"value":18358.34,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been retained by the Issuer to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of restricted stock units previously reported."}],"balance_after":86459,"source":{"system":"sec-edgar","filing":"0001464521-26-000119","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1464521/000146452126000119/form4.xml","form_type":"4"}},{"id":691827,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21616,"kind":"person","name":"Rogers Campbell","position":1,"cik":"0001585724","reported_name":"Rogers Campbell","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-08-10T21:17:35.000Z","date":"2026-08-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":1635,"price":27.19,"value":44455.65,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been retained by the Issuer to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of restricted stock units previously reported."}],"balance_after":87096,"source":{"system":"sec-edgar","filing":"0001464521-26-000119","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1464521/000146452126000119/form4.xml","form_type":"4"}},{"id":706779,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21616,"kind":"person","name":"Rogers Campbell","position":1,"cik":"0001585724","reported_name":"Rogers Campbell","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options","published_at":"2026-07-17T21:54:51.000Z","date":"2026-07-15","kind":"exercise","planned":true,"acquired":false,"shares":9219,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in monthly installments until August 7, 2029, subject to continued service through the applicable vesting date."}],"balance_after":92191,"derivative":{"exercise_price":19,"expiration_date":"2035-08-07","underlying":"Common Stock","underlying_shares":9219},"source":{"system":"sec-edgar","filing":"0001464521-26-000103","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1464521/000146452126000103/form4.xml","form_type":"4"}},{"id":706778,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21616,"kind":"person","name":"Rogers Campbell","position":1,"cik":"0001585724","reported_name":"Rogers Campbell","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-07-17T21:54:51.000Z","date":"2026-07-15","kind":"sale","planned":true,"acquired":false,"shares":9219,"price":25.72,"value":237112.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 12, 2025."}],"balance_after":88731,"source":{"system":"sec-edgar","filing":"0001464521-26-000103","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1464521/000146452126000103/form4.xml","form_type":"4"}},{"id":706777,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21616,"kind":"person","name":"Rogers Campbell","position":1,"cik":"0001585724","reported_name":"Rogers Campbell","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-07-17T21:54:51.000Z","date":"2026-07-15","kind":"exercise","planned":true,"acquired":true,"shares":9219,"price":19,"value":175161.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 12, 2025."}],"balance_after":97950,"source":{"system":"sec-edgar","filing":"0001464521-26-000103","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1464521/000146452126000103/form4.xml","form_type":"4"}},{"id":733989,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21616,"kind":"person","name":"Rogers Campbell","position":1,"cik":"0001585724","reported_name":"Rogers Campbell","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-06-17T21:39:16.000Z","date":"2026-06-15","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise reported on this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in monthly installments until July 1, 2027, subject to continued service through the applicable vesting date."}],"balance_after":71633,"derivative":{"exercise_price":2.22,"expiration_date":"2033-07-10","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001464521-26-000078","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1464521/000146452126000078/form4.xml","form_type":"4"}},{"id":733988,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21616,"kind":"person","name":"Rogers Campbell","position":1,"cik":"0001585724","reported_name":"Rogers Campbell","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-06-17T21:39:16.000Z","date":"2026-06-15","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":2.22,"value":22200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise reported on this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 12, 2025."}],"balance_after":88731,"source":{"system":"sec-edgar","filing":"0001464521-26-000078","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1464521/000146452126000078/form4.xml","form_type":"4"}},{"id":769935,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21616,"kind":"person","name":"Rogers Campbell","position":1,"cik":"0001585724","reported_name":"Rogers Campbell","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options","published_at":"2026-05-20T21:55:39.000Z","date":"2026-05-18","kind":"exercise","planned":true,"acquired":false,"shares":9219,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in monthly installments until August 7, 2029, subject to continued service through the applicable vesting date."}],"balance_after":101410,"derivative":{"exercise_price":19,"expiration_date":"2035-08-07","underlying":"Common Stock","underlying_shares":9219},"source":{"system":"sec-edgar","filing":"0001464521-26-000073","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1464521/000146452126000073/form4.xml","form_type":"4"}},{"id":769934,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21616,"kind":"person","name":"Rogers Campbell","position":1,"cik":"0001585724","reported_name":"Rogers Campbell","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-05-20T21:55:39.000Z","date":"2026-05-18","kind":"sale","planned":true,"acquired":false,"shares":9219,"price":28.34,"value":261266.46,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 12, 2025."}],"balance_after":78731,"source":{"system":"sec-edgar","filing":"0001464521-26-000073","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1464521/000146452126000073/form4.xml","form_type":"4"}},{"id":769933,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21616,"kind":"person","name":"Rogers Campbell","position":1,"cik":"0001585724","reported_name":"Rogers Campbell","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-05-20T21:55:39.000Z","date":"2026-05-18","kind":"exercise","planned":true,"acquired":true,"shares":9219,"price":19,"value":175161.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 12, 2025."}],"balance_after":87950,"source":{"system":"sec-edgar","filing":"0001464521-26-000073","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1464521/000146452126000073/form4.xml","form_type":"4"}},{"id":786718,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21616,"kind":"person","name":"Rogers Campbell","position":1,"cik":"0001585724","reported_name":"Rogers Campbell","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-05-08T22:45:34.000Z","date":"2026-05-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":637,"price":29.98,"value":19097.26,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been retained by the Issuer to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of restricted stock units previously reported."}],"balance_after":78731,"source":{"system":"sec-edgar","filing":"0001464521-26-000061","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1464521/000146452126000061/form4.xml","form_type":"4"}},{"id":786717,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21616,"kind":"person","name":"Rogers Campbell","position":1,"cik":"0001585724","reported_name":"Rogers Campbell","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-05-08T22:45:34.000Z","date":"2026-05-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":1634,"price":30.29,"value":49493.86,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been retained by the Issuer to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of restricted stock units previously reported."}],"balance_after":79368,"source":{"system":"sec-edgar","filing":"0001464521-26-000061","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1464521/000146452126000061/form4.xml","form_type":"4"}},{"id":816234,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21616,"kind":"person","name":"Rogers Campbell","position":1,"cik":"0001585724","reported_name":"Rogers Campbell","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-04-03T22:15:31.000Z","date":"2026-04-01","kind":"exercise","planned":true,"acquired":false,"shares":40766,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vests and becomes exercisable in monthly installments until July 1, 2027, subject to continued service through the applicable vesting date."}],"balance_after":81633,"derivative":{"exercise_price":2.22,"expiration_date":"2033-07-10","underlying":"Common Stock","underlying_shares":40766},"source":{"system":"sec-edgar","filing":"0001464521-26-000052","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1464521/000146452126000052/form4.xml","form_type":"4"}},{"id":816233,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21616,"kind":"person","name":"Rogers Campbell","position":1,"cik":"0001585724","reported_name":"Rogers Campbell","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-04-03T22:15:31.000Z","date":"2026-04-01","kind":"exercise","planned":true,"acquired":false,"shares":19111,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise reported on this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vests and becomes exercisable in monthly installments until July 1, 2027, subject to continued service through the applicable vesting date."}],"balance_after":122399,"derivative":{"exercise_price":2.22,"expiration_date":"2033-07-10","underlying":"Common Stock","underlying_shares":19111},"source":{"system":"sec-edgar","filing":"0001464521-26-000052","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1464521/000146452126000052/form4.xml","form_type":"4"}},{"id":816232,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21616,"kind":"person","name":"Rogers Campbell","position":1,"cik":"0001585724","reported_name":"Rogers Campbell","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-04-03T22:15:31.000Z","date":"2026-04-01","kind":"exercise","planned":true,"acquired":false,"shares":291,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise reported on this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These stock options are fully exercisable."}],"balance_after":3298,"derivative":{"exercise_price":8.33,"expiration_date":"2031-04-12","underlying":"Common Stock","underlying_shares":291},"source":{"system":"sec-edgar","filing":"0001464521-26-000052","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1464521/000146452126000052/form4.xml","form_type":"4"}},{"id":816231,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21616,"kind":"person","name":"Rogers Campbell","position":1,"cik":"0001585724","reported_name":"Rogers Campbell","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options","published_at":"2026-04-03T22:15:31.000Z","date":"2026-04-01","kind":"exercise","planned":true,"acquired":false,"shares":6849,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These stock options are fully exercisable."}],"balance_after":0,"derivative":{"exercise_price":2.22,"expiration_date":"2033-07-10","underlying":"Common Stock","underlying_shares":6849},"source":{"system":"sec-edgar","filing":"0001464521-26-000052","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1464521/000146452126000052/form4.xml","form_type":"4"}},{"id":816230,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21616,"kind":"person","name":"Rogers Campbell","position":1,"cik":"0001585724","reported_name":"Rogers Campbell","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-04-03T22:15:31.000Z","date":"2026-04-01","kind":"sale","planned":true,"acquired":false,"shares":64533,"price":24.64,"value":1590093.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Includes the sale of 16,918 shares of common stock held and the option exercise and sale of 47,615 shares reported on this Form 4 that were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 12, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at price ranging from $24.03 to $25.27. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":81002,"source":{"system":"sec-edgar","filing":"0001464521-26-000052","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1464521/000146452126000052/form4.xml","form_type":"4"}},{"id":816229,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21616,"kind":"person","name":"Rogers Campbell","position":1,"cik":"0001585724","reported_name":"Rogers Campbell","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-04-03T22:15:31.000Z","date":"2026-04-01","kind":"exercise","planned":true,"acquired":true,"shares":6849,"price":2.22,"value":15204.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 12, 2025."}],"balance_after":145535,"source":{"system":"sec-edgar","filing":"0001464521-26-000052","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1464521/000146452126000052/form4.xml","form_type":"4"}},{"id":816228,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21616,"kind":"person","name":"Rogers Campbell","position":1,"cik":"0001585724","reported_name":"Rogers Campbell","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-04-03T22:15:31.000Z","date":"2026-04-01","kind":"exercise","planned":true,"acquired":true,"shares":40766,"price":2.22,"value":90500.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 12, 2025."}],"balance_after":138686,"source":{"system":"sec-edgar","filing":"0001464521-26-000052","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1464521/000146452126000052/form4.xml","form_type":"4"}},{"id":816227,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21616,"kind":"person","name":"Rogers Campbell","position":1,"cik":"0001585724","reported_name":"Rogers Campbell","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-04-03T22:15:31.000Z","date":"2026-04-01","kind":"exercise","planned":true,"acquired":true,"shares":19111,"price":2.22,"value":42426.42,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise reported on this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 12, 2025."}],"balance_after":97920,"source":{"system":"sec-edgar","filing":"0001464521-26-000052","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1464521/000146452126000052/form4.xml","form_type":"4"}},{"id":816226,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21616,"kind":"person","name":"Rogers Campbell","position":1,"cik":"0001585724","reported_name":"Rogers Campbell","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-04-03T22:15:31.000Z","date":"2026-04-01","kind":"exercise","planned":true,"acquired":true,"shares":291,"price":8.33,"value":2424.03,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise reported on this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 12, 2025."}],"balance_after":78809,"source":{"system":"sec-edgar","filing":"0001464521-26-000052","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1464521/000146452126000052/form4.xml","form_type":"4"}},{"id":830752,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21616,"kind":"person","name":"Rogers Campbell","position":1,"cik":"0001585724","reported_name":"Rogers Campbell","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-03-23T22:33:35.000Z","date":"2026-03-19","kind":"exercise","planned":true,"acquired":false,"shares":47615,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests and becomes exercisable in monthly installments until July 1, 2027, subject to continued service through the applicable vesting date."}],"balance_after":141510,"derivative":{"exercise_price":2.22,"expiration_date":"2033-07-10","underlying":"Common Stock","underlying_shares":47615},"source":{"system":"sec-edgar","filing":"0001464521-26-000048","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1464521/000146452126000048/form4.xml","form_type":"4"}},{"id":830751,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21616,"kind":"person","name":"Rogers Campbell","position":1,"cik":"0001585724","reported_name":"Rogers Campbell","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-03-23T22:33:35.000Z","date":"2026-03-19","kind":"exercise","planned":true,"acquired":false,"shares":19402,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise reported on this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests and becomes exercisable in monthly installments until July 1, 2027, subject to continued service through the applicable vesting date."}],"balance_after":189125,"derivative":{"exercise_price":2.22,"expiration_date":"2033-07-10","underlying":"Common Stock","underlying_shares":19402},"source":{"system":"sec-edgar","filing":"0001464521-26-000048","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1464521/000146452126000048/form4.xml","form_type":"4"}},{"id":830750,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21616,"kind":"person","name":"Rogers Campbell","position":1,"cik":"0001585724","reported_name":"Rogers Campbell","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-23T22:33:35.000Z","date":"2026-03-19","kind":"sale","planned":true,"acquired":false,"shares":64533,"price":25.6928,"value":1658033.4624,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Includes the sale of 16,918 shares of common stock held and the option exercise and sale of 47,615 shares reported on this Form 4 that were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 12, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at price ranging from $25.00 to $28.00. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":78518,"source":{"system":"sec-edgar","filing":"0001464521-26-000048","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1464521/000146452126000048/form4.xml","form_type":"4"}},{"id":830749,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21616,"kind":"person","name":"Rogers Campbell","position":1,"cik":"0001585724","reported_name":"Rogers Campbell","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-23T22:33:35.000Z","date":"2026-03-19","kind":"exercise","planned":true,"acquired":true,"shares":47615,"price":2.22,"value":105705.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 12, 2025."}],"balance_after":143051,"source":{"system":"sec-edgar","filing":"0001464521-26-000048","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1464521/000146452126000048/form4.xml","form_type":"4"}},{"id":830748,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21616,"kind":"person","name":"Rogers Campbell","position":1,"cik":"0001585724","reported_name":"Rogers Campbell","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-23T22:33:35.000Z","date":"2026-03-19","kind":"exercise","planned":true,"acquired":true,"shares":19402,"price":2.22,"value":43072.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise reported on this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 12, 2025."}],"balance_after":95436,"source":{"system":"sec-edgar","filing":"0001464521-26-000048","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1464521/000146452126000048/form4.xml","form_type":"4"}},{"id":900889,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21616,"kind":"person","name":"Rogers Campbell","position":1,"cik":"0001585724","reported_name":"Rogers Campbell","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-02-18T01:07:50.000Z","date":"2026-02-12","kind":"exercise","planned":true,"acquired":false,"shares":7906,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vests and becomes exercisable in monthly installments until July 1, 2027, subject to continued service through the applicable vesting date."}],"balance_after":208527,"derivative":{"exercise_price":2.22,"expiration_date":"2033-07-10","underlying":"Common Stock","underlying_shares":7906},"source":{"system":"sec-edgar","filing":"0001464521-26-000018","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1464521/000146452126000018/form4.xml","form_type":"4"}},{"id":900888,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21616,"kind":"person","name":"Rogers Campbell","position":1,"cik":"0001585724","reported_name":"Rogers Campbell","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-02-18T01:07:50.000Z","date":"2026-02-12","kind":"exercise","planned":true,"acquired":false,"shares":19401,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise reported on this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vests and becomes exercisable in monthly installments until July 1, 2027, subject to continued service through the applicable vesting date."}],"balance_after":216433,"derivative":{"exercise_price":2.22,"expiration_date":"2033-07-10","underlying":"Common Stock","underlying_shares":19401},"source":{"system":"sec-edgar","filing":"0001464521-26-000018","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1464521/000146452126000018/form4.xml","form_type":"4"}},{"id":900887,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21616,"kind":"person","name":"Rogers Campbell","position":1,"cik":"0001585724","reported_name":"Rogers Campbell","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-02-18T01:07:50.000Z","date":"2026-02-12","kind":"exercise","planned":true,"acquired":false,"shares":39709,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These stock options are fully exercisable."}],"balance_after":0,"derivative":{"exercise_price":8.33,"expiration_date":"2026-03-09","underlying":"Common Stock","underlying_shares":39709},"source":{"system":"sec-edgar","filing":"0001464521-26-000018","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1464521/000146452126000018/form4.xml","form_type":"4"}},{"id":900886,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21616,"kind":"person","name":"Rogers Campbell","position":1,"cik":"0001585724","reported_name":"Rogers Campbell","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-18T01:07:50.000Z","date":"2026-02-12","kind":"sale","planned":true,"acquired":false,"shares":65153,"price":24.4883,"value":1595486.2099,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Includes the sale of 17,538 shares of common stock held and the option exercise and sale of 47,615 shares reported on this Form 4 that were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 12, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at price ranging from $22.90 to $26.51. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":76034,"source":{"system":"sec-edgar","filing":"0001464521-26-000018","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1464521/000146452126000018/form4.xml","form_type":"4"}},{"id":900885,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21616,"kind":"person","name":"Rogers Campbell","position":1,"cik":"0001585724","reported_name":"Rogers Campbell","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-18T01:07:50.000Z","date":"2026-02-12","kind":"exercise","planned":true,"acquired":true,"shares":7906,"price":2.22,"value":17551.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 12, 2025."}],"balance_after":141187,"source":{"system":"sec-edgar","filing":"0001464521-26-000018","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1464521/000146452126000018/form4.xml","form_type":"4"}},{"id":900884,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21616,"kind":"person","name":"Rogers Campbell","position":1,"cik":"0001585724","reported_name":"Rogers Campbell","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-18T01:07:50.000Z","date":"2026-02-12","kind":"exercise","planned":true,"acquired":true,"shares":39709,"price":8.33,"value":330775.97,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 12, 2025."}],"balance_after":133281,"source":{"system":"sec-edgar","filing":"0001464521-26-000018","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1464521/000146452126000018/form4.xml","form_type":"4"}},{"id":900883,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21616,"kind":"person","name":"Rogers Campbell","position":1,"cik":"0001585724","reported_name":"Rogers Campbell","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-18T01:07:50.000Z","date":"2026-02-12","kind":"exercise","planned":true,"acquired":true,"shares":19401,"price":2.22,"value":43070.22,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise reported on this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 12, 2025."}],"balance_after":93572,"source":{"system":"sec-edgar","filing":"0001464521-26-000018","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1464521/000146452126000018/form4.xml","form_type":"4"}},{"id":911738,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21616,"kind":"person","name":"Rogers Campbell","position":1,"cik":"0001585724","reported_name":"Rogers Campbell","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-02-11T01:21:16.000Z","date":"2026-02-06","kind":"grant","planned":false,"acquired":true,"shares":94488,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests 1/48 on each monthly anniversary of the Vesting Commencement Date, subject to continued service through the applicable vesting date."}],"balance_after":94488,"derivative":{"exercise_price":27.74,"expiration_date":"2036-02-06","underlying":"Common Stock","underlying_shares":94488},"source":{"system":"sec-edgar","filing":"0001464521-26-000012","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1464521/000146452126000012/form4.xml","form_type":"4"}},{"id":911737,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21616,"kind":"person","name":"Rogers Campbell","position":1,"cik":"0001585724","reported_name":"Rogers Campbell","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-11T01:21:16.000Z","date":"2026-02-06","kind":"grant","planned":false,"acquired":true,"shares":54073,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted stock units (\"RSUs\"), with a vesting commencement date of February 6, 2026 (the \"Vesting Commencement Date\"). 1/16th of the RSUs vest on each quarterly anniversary of the Vesting Commencement Date,\nsubject to continued service through the applicable vesting date."}],"balance_after":74171,"source":{"system":"sec-edgar","filing":"0001464521-26-000012","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1464521/000146452126000012/form4.xml","form_type":"4"}},{"id":911736,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21616,"kind":"person","name":"Rogers Campbell","position":1,"cik":"0001585724","reported_name":"Rogers Campbell","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-11T01:21:16.000Z","date":"2026-02-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":515,"price":27.74,"value":14286.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been retained by the Issuer to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of restricted stock units previously reported."}],"balance_after":20098,"source":{"system":"sec-edgar","filing":"0001464521-26-000012","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1464521/000146452126000012/form4.xml","form_type":"4"}},{"id":1001923,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21616,"kind":"person","name":"Rogers Campbell","position":1,"cik":"0001585724","reported_name":"Rogers Campbell","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-11-13T01:46:38.000Z","date":"2025-11-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":439,"price":32.56,"value":14293.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been retained by the Issuer to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of restricted stock units previously reported."}],"balance_after":20613,"source":{"system":"sec-edgar","filing":"0001464521-25-000033","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1464521/000146452125000033/form4.xml","form_type":"4"}},{"id":1070079,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21616,"kind":"person","name":"Rogers Campbell","position":1,"cik":"0001585724","reported_name":"Rogers Campbell","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options","published_at":"2025-08-12T01:01:03.000Z","date":"2025-08-07","kind":"grant","planned":false,"acquired":true,"shares":110629,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests 1/48 on each monthly anniversary of the Vesting Commencement Date, subject to continued service through the applicable vesting date."}],"balance_after":110629,"derivative":{"exercise_price":19,"expiration_date":"2035-08-07","underlying":"Common Stock","underlying_shares":110629},"source":{"system":"sec-edgar","filing":"0001628280-25-039733","document":"wk-form4_1754960459.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1464521/000162828025039733/wk-form4_1754960459.xml","form_type":"4"}},{"id":1070078,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21616,"kind":"person","name":"Rogers Campbell","position":1,"cik":"0001585724","reported_name":"Rogers Campbell","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-08-12T01:01:03.000Z","date":"2025-08-07","kind":"grant","planned":false,"acquired":true,"shares":21052,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\"), with a vesting commencement date of August 7, 2025 (the \"Vesting Commencement Date\"). 1/16th of the RSUs vest on each quarterly anniversary of the Vesting Commencement Date, subject to continued service through the applicable vesting date."}],"balance_after":21052,"source":{"system":"sec-edgar","filing":"0001628280-25-039733","document":"wk-form4_1754960459.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1464521/000162828025039733/wk-form4_1754960459.xml","form_type":"4"}},{"id":2542320,"issuer":{"id":7318,"kind":"organization","name":"InspireMD, Inc.","symbol":"NSPR"},"owners":[{"id":21616,"kind":"person","name":"Rogers Campbell","position":1,"cik":"0001585724","reported_name":"Rogers Campbell","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock (right to buy)","published_at":"2021-10-14T21:00:45.000Z","date":"2021-10-13","kind":"grant","acquired":true,"shares":5749,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and become exercisable in three equal installments, with 1/3 vesting on each of October 13, 2022, October 13, 2023 and October 13, 2024, subject to the Reporting Person's continued service."}],"balance_after":5749,"derivative":{"exercise_price":4.12,"expiration_date":"2031-10-13","underlying":"Common Stock","underlying_shares":5749},"source":{"system":"sec-edgar","filing":"0001493152-21-025451","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1433607/000149315221025451/ownership.xml","form_type":"4"}},{"id":2542319,"issuer":{"id":7318,"kind":"organization","name":"InspireMD, Inc.","symbol":"NSPR"},"owners":[{"id":21616,"kind":"person","name":"Rogers Campbell","position":1,"cik":"0001585724","reported_name":"Rogers Campbell","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-14T21:00:45.000Z","date":"2021-10-13","kind":"grant","acquired":true,"shares":17248,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of October 13, 2022, October 13, 2023 and October 13, 2024, subject to the Reporting Person's continued service."}],"balance_after":27960,"source":{"system":"sec-edgar","filing":"0001493152-21-025451","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1433607/000149315221025451/ownership.xml","form_type":"4"}},{"id":3041003,"issuer":{"id":7318,"kind":"organization","name":"InspireMD, Inc.","symbol":"NSPR"},"owners":[{"id":21616,"kind":"person","name":"Rogers Campbell","position":1,"cik":"0001585724","reported_name":"Rogers Campbell","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock (right to buy)","published_at":"2020-09-02T16:55:52.000Z","date":"2020-08-31","kind":"grant","acquired":true,"shares":52678,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and become exercisable in three equal installments, with 1/3 vesting on each of August 31, 2021, August 31, 2022 and August 31, 2023, subject to the Reporting Person's continued service."}],"balance_after":52692,"derivative":{"exercise_price":0.39,"expiration_date":"2030-08-31","underlying":"Common Stock","underlying_shares":52678},"source":{"system":"sec-edgar","filing":"0001493152-20-017125","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1433607/000149315220017125/ownership.xml","form_type":"4"}},{"id":3041002,"issuer":{"id":7318,"kind":"organization","name":"InspireMD, Inc.","symbol":"NSPR"},"owners":[{"id":21616,"kind":"person","name":"Rogers Campbell","position":1,"cik":"0001585724","reported_name":"Rogers Campbell","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-02T16:55:52.000Z","date":"2020-08-31","kind":"grant","acquired":true,"shares":158033,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of August 31, 2021, August 31, 2022 and August 31, 2023, subject to the Reporting Person's continued service."}],"balance_after":160635,"source":{"system":"sec-edgar","filing":"0001493152-20-017125","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1433607/000149315220017125/ownership.xml","form_type":"4"}},{"id":3384378,"issuer":{"id":154132,"kind":"organization","name":"Corindus Vascular Robotics, Inc.","symbol":"CVRS"},"owners":[{"id":21616,"kind":"person","name":"Rogers Campbell","position":1,"cik":"0001585724","reported_name":"Rogers Campbell","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified stock option (right to buy)","published_at":"2019-10-31T16:51:43.000Z","date":"2019-10-29","kind":"disposition_to_issuer","acquired":false,"shares":17857,"price":2.6,"value":46428.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 29, 2019, Siemens Medical Solutions USA, Inc., a Delaware corporation (\"Parent\"), acquired the Issuer pursuant to that certain Agreement and Plan of Merger entered into by and among the Issuer, Parent and Corpus Merger Inc., a Delaware corporation and wholly-owned subsidiary of Parent (\"Merger Sub\"), dated as of August 7, 2019 (the \"Merger Agreement\"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer, with the Issuer surviving such merger as a wholly-owned subsidiary of Parent (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"At the Effective Time, each outstanding and unexercised option to purchase shares of the Issuer's common stock automatically converted into the right to receive a cash payment equal to the product of (i) the excess, if any, of $4.28 over the per share exercise price of such option, and (ii) the number of shares of the Issuer's common stock subject to such option as of the Effective Time, without interest and net of any applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option provided for vesting over a period of three years with 33.33% vesting on the first anniversary of issuance and 8.334% vesting at the end of each calendar quarter thereafter."}],"balance_after":0,"derivative":{"exercise_price":1.68,"expiration_date":"2027-06-21","underlying":"Common Stock","underlying_shares":17857},"source":{"system":"sec-edgar","filing":"0001387131-19-008133","document":"rogers-form4_102919.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1528557/000138713119008133/rogers-form4_102919.xml","form_type":"4"}},{"id":3384377,"issuer":{"id":154132,"kind":"organization","name":"Corindus Vascular Robotics, Inc.","symbol":"CVRS"},"owners":[{"id":21616,"kind":"person","name":"Rogers Campbell","position":1,"cik":"0001585724","reported_name":"Rogers Campbell","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified stock option (right to buy)","published_at":"2019-10-31T16:51:43.000Z","date":"2019-10-29","kind":"disposition_to_issuer","acquired":false,"shares":27272,"price":3.18,"value":86724.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 29, 2019, Siemens Medical Solutions USA, Inc., a Delaware corporation (\"Parent\"), acquired the Issuer pursuant to that certain Agreement and Plan of Merger entered into by and among the Issuer, Parent and Corpus Merger Inc., a Delaware corporation and wholly-owned subsidiary of Parent (\"Merger Sub\"), dated as of August 7, 2019 (the \"Merger Agreement\"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer, with the Issuer surviving such merger as a wholly-owned subsidiary of Parent (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"At the Effective Time, each outstanding and unexercised option to purchase shares of the Issuer's common stock automatically converted into the right to receive a cash payment equal to the product of (i) the excess, if any, of $4.28 over the per share exercise price of such option, and (ii) the number of shares of the Issuer's common stock subject to such option as of the Effective Time, without interest and net of any applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option provided for vesting over a period of three years with 33.33% vesting on the first anniversary of issuance and 8.334% vesting at the end of each calendar quarter thereafter."}],"balance_after":0,"derivative":{"exercise_price":1.1,"expiration_date":"2026-09-26","underlying":"Common Stock","underlying_shares":27272},"source":{"system":"sec-edgar","filing":"0001387131-19-008133","document":"rogers-form4_102919.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1528557/000138713119008133/rogers-form4_102919.xml","form_type":"4"}},{"id":3384376,"issuer":{"id":154132,"kind":"organization","name":"Corindus Vascular Robotics, Inc.","symbol":"CVRS"},"owners":[{"id":21616,"kind":"person","name":"Rogers Campbell","position":1,"cik":"0001585724","reported_name":"Rogers Campbell","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified stock option (right to buy)","published_at":"2019-10-31T16:51:43.000Z","date":"2019-10-29","kind":"disposition_to_issuer","acquired":false,"shares":98522,"price":2.25,"value":221674.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 29, 2019, Siemens Medical Solutions USA, Inc., a Delaware corporation (\"Parent\"), acquired the Issuer pursuant to that certain Agreement and Plan of Merger entered into by and among the Issuer, Parent and Corpus Merger Inc., a Delaware corporation and wholly-owned subsidiary of Parent (\"Merger Sub\"), dated as of August 7, 2019 (the \"Merger Agreement\"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer, with the Issuer surviving such merger as a wholly-owned subsidiary of Parent (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"At the Effective Time, each outstanding and unexercised option to purchase shares of the Issuer's common stock automatically converted into the right to receive a cash payment equal to the product of (i) the excess, if any, of $4.28 over the per share exercise price of such option, and (ii) the number of shares of the Issuer's common stock subject to such option as of the Effective Time, without interest and net of any applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option provided for vesting in two equal installments at the end of each anniversary of the date of grant."}],"balance_after":0,"derivative":{"exercise_price":2.03,"expiration_date":"2026-02-03","underlying":"Common Stock","underlying_shares":98522},"source":{"system":"sec-edgar","filing":"0001387131-19-008133","document":"rogers-form4_102919.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1528557/000138713119008133/rogers-form4_102919.xml","form_type":"4"}},{"id":3384375,"issuer":{"id":154132,"kind":"organization","name":"Corindus Vascular Robotics, Inc.","symbol":"CVRS"},"owners":[{"id":21616,"kind":"person","name":"Rogers Campbell","position":1,"cik":"0001585724","reported_name":"Rogers Campbell","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-31T16:51:43.000Z","date":"2019-10-29","kind":"disposition_to_issuer","acquired":false,"shares":90149,"price":4.28,"value":385837.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 29, 2019, Siemens Medical Solutions USA, Inc., a Delaware corporation (\"Parent\"), acquired the Issuer pursuant to that certain Agreement and Plan of Merger entered into by and among the Issuer, Parent and Corpus Merger Inc., a Delaware corporation and wholly-owned subsidiary of Parent (\"Merger Sub\"), dated as of August 7, 2019 (the \"Merger Agreement\"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer, with the Issuer surviving such merger as a wholly-owned subsidiary of Parent (the \"Merger\")."},{"field":"shares","element":"transactionShares","label":"F2","text":"These shares represent 69,412 shares of the Issuer's common stock and 20,737 restricted stock units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the effective time of the Merger (the \"Effective Time\"), which occurred on October 29, 2019, (i) each outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $4.28 in cash, without interest and less any applicable withholding taxes, and (ii) each outstanding RSU converted into the right to receive a cash payment equal to the product of (a) $4.28 and (b) the number of shares of the Issuer's common stock underlying the RSU as of the Effective Time, without interest and net of any applicable withholding taxes."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001387131-19-008133","document":"rogers-form4_102919.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1528557/000138713119008133/rogers-form4_102919.xml","form_type":"4"}},{"id":3536217,"issuer":{"id":154132,"kind":"organization","name":"Corindus Vascular Robotics, Inc.","symbol":"CVRS"},"owners":[{"id":21616,"kind":"person","name":"Rogers Campbell","position":1,"cik":"0001585724","reported_name":"Rogers Campbell","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-07T18:36:27.000Z","date":"2019-05-03","kind":"grant","acquired":true,"shares":27649,"price":2.17,"value":59998.33,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The common stock represents shares issuable upon vesting of restricted stock units (RSUs) granted as part of the director's 2019 annual equity award. The RSUs provide for vesting in quarterly installments on August 3, 2019, November 3, 2019, February 3, 2020 and May 3, 2020, subject to the reporting person's continuous service with Corindus Vascular Robotics, Inc. (Corindus) through each such vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 53,326 shares of common stock related to RSUs granted as part of the director's 2018 annual equity award which provided for vesting in quarterly installments on August 31, 2018, November 30, 2018, February 28, 2019 and May 31 2019, subject to the reporting person's continuous service with Corindus through each such vesting date."}],"balance_after":90149,"source":{"system":"sec-edgar","filing":"0001387131-19-003402","document":"rogers-form4_050319.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1528557/000138713119003402/rogers-form4_050319.xml","form_type":"4"}},{"id":3672201,"issuer":{"id":7318,"kind":"organization","name":"InspireMD, Inc.","symbol":"NSPR"},"owners":[{"id":21616,"kind":"person","name":"Rogers Campbell","position":1,"cik":"0001585724","reported_name":"Rogers Campbell","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-06T21:30:38.000Z","date":"2019-02-04","kind":"grant","acquired":true,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":130011,"source":{"system":"sec-edgar","filing":"0001493152-19-001462","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1433607/000149315219001462/ownership.xml","form_type":"4"}},{"id":3907794,"issuer":{"id":154132,"kind":"organization","name":"Corindus Vascular Robotics, Inc.","symbol":"CVRS"},"owners":[{"id":21616,"kind":"person","name":"Rogers Campbell","position":1,"cik":"0001585724","reported_name":"Rogers Campbell","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-04T18:01:23.000Z","date":"2018-05-31","kind":"grant","acquired":true,"shares":53326,"price":0.7501,"value":39999.8326,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The common stock represents shares issuable upon vesting of restricted stock units (RSUs) granted as part of the director's 2018 annual equity award. The RSUs provide for vesting in quarterly installments on August 31, 2018, November 30, 2018, February 28, 2019 and May 31, 2019, subject to the reporting person's continuous service with Corindus Vascular Robotics, Inc. (Corindus) through each such vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 9,174 shares of common stock related to RSUs granted as part of the director's 2017 annual equity award which provided for initial vesting of one-quarter of the granted units and subsequent quarterly vesting on December 22, 2017, March 22, 2018 and June 22, 2018, subject to the reporting person's continuous service with Corindus through each such vesting date."}],"balance_after":62500,"source":{"system":"sec-edgar","filing":"0001387131-18-002521","document":"rogers-form4_053118.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1528557/000138713118002521/rogers-form4_053118.xml","form_type":"4"}},{"id":4009920,"issuer":{"id":154132,"kind":"organization","name":"Corindus Vascular Robotics, Inc.","symbol":"CVRS"},"owners":[{"id":21616,"kind":"person","name":"Rogers Campbell","position":1,"cik":"0001585724","reported_name":"Rogers Campbell","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-06T19:04:38.000Z","date":"2017-12-15","kind":"grant","acquired":true,"shares":9174,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The common stock represents shares issuable upon vesting of restricted stock units granted as part of the director's annual equity award. The RSUs were initially vested with respect to one quarter of the granted units. The remaining quarterly installments will vest on December 22, 2017, March 22, 2018 and June 22, 2018, subject to the reporting person's continuous service with Corindus Vascular Robotics, Inc. through each such vesting date."}],"balance_after":9174,"source":{"system":"sec-edgar","filing":"0001387131-18-000947","document":"rogers-form4a_121517.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1528557/000138713118000947/rogers-form4a_121517.xml","form_type":"4/A","original_submission_date":"2017-12-19"}},{"id":4125911,"issuer":{"id":154132,"kind":"organization","name":"Corindus Vascular Robotics, Inc.","symbol":"CVRS"},"owners":[{"id":21616,"kind":"person","name":"Rogers Campbell","position":1,"cik":"0001585724","reported_name":"Rogers Campbell","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-12-19T20:17:46.000Z","date":"2017-12-15","kind":"grant","acquired":true,"shares":9174,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock, par value $0.0001 per share, of Corindus Vascular Robotics, Inc."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on December 15, 2017 as part of the director's annual equity award with vesting beginning as of June 22, 2017, the date of the 2017 Annual Meeting of Stockholders, The restricted stock units vest in four equal quarterly installments on September 22, 2017, December 22, 2017, March 22, 2018 and June 22, 2018, subject to the reporting person's continuous service with Corindus Vascular Robotics, Inc. through each such vesting date. Vested shares will be delivered to the reporting person within five days of each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on December 15, 2017 as part of the director's annual equity award with vesting beginning as of June 22, 2017, the date of the 2017 Annual Meeting of Stockholders, The restricted stock units vest in four equal quarterly installments on September 22, 2017, December 22, 2017, March 22, 2018 and June 22, 2018, subject to the reporting person's continuous service with Corindus Vascular Robotics, Inc. through each such vesting date. Vested shares will be delivered to the reporting person within five days of each such vesting date."}],"balance_after":9174,"derivative":{"underlying":"Common Stock","underlying_shares":9174},"source":{"system":"sec-edgar","filing":"0001387131-17-005911","document":"rogers-form4_121517.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1528557/000138713117005911/rogers-form4_121517.xml","form_type":"4"}},{"id":4272361,"issuer":{"id":154132,"kind":"organization","name":"Corindus Vascular Robotics, Inc.","symbol":"CVRS"},"owners":[{"id":21616,"kind":"person","name":"Rogers Campbell","position":1,"cik":"0001585724","reported_name":"Rogers Campbell","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified stock option (right to buy)","published_at":"2017-06-26T21:04:41.000Z","date":"2017-06-22","kind":"grant","acquired":true,"shares":17857,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares vest over a period of three years with 33.33% vesting on the first anniversary of the issuance date and 8.334% vesting at the end of each calendar quarter thereafter."}],"balance_after":17857,"derivative":{"exercise_price":1.68,"expiration_date":"2027-06-21","underlying":"Common Stock","underlying_shares":17857},"source":{"system":"sec-edgar","filing":"0001387131-17-003457","document":"rogers-form4_062217.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1528557/000138713117003457/rogers-form4_062217.xml","form_type":"4"}},{"id":4527034,"issuer":{"id":7318,"kind":"organization","name":"InspireMD, Inc.","symbol":"NSPR"},"owners":[{"id":21616,"kind":"person","name":"Rogers Campbell","position":1,"cik":"0001585724","reported_name":"Rogers Campbell","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (right to buy)","published_at":"2016-12-09T13:44:25.000Z","date":"2016-12-07","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in three equal annual installments, with 1/3 becoming exercisable on each of December 7, 2017, December 7, 2018 and December 7, 2019, subject to Mr. Rogers' continued service."}],"balance_after":12500,"derivative":{"exercise_price":3.04,"expiration_date":"2026-12-07","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001493152-16-015779","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1433607/000149315216015779/form4.xml","form_type":"4"}},{"id":4592534,"issuer":{"id":154132,"kind":"organization","name":"Corindus Vascular Robotics, Inc.","symbol":"CVRS"},"owners":[{"id":21616,"kind":"person","name":"Rogers Campbell","position":1,"cik":"0001585724","reported_name":"Rogers Campbell","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified stock option (right to buy)","published_at":"2016-09-29T17:41:42.000Z","date":"2016-09-27","kind":"grant","acquired":true,"shares":27272,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting start date is June 23, 2016. The options vest over a period of three years with 33.33% vesting on the first anniversary of the vesting date and 8.334% vesting at the end of each calendar quarter thereafter."}],"balance_after":27272,"derivative":{"exercise_price":1.1,"expiration_date":"2026-09-26","underlying":"Common Stock","underlying_shares":27272},"source":{"system":"sec-edgar","filing":"0001387131-16-007141","document":"rogers-form4_092716.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1528557/000138713116007141/rogers-form4_092716.xml","form_type":"4"}}]}